Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

NRG Therapeutics

- PMLiVE

NRG Therapeutics appoints Paul Thompson as Chief Development Officer

Thompson previously held senior roles at Mission Therapeutics and GSK

- PMLiVE

NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment

NRG received a £2.68m Innovative UK award to help fund research into treatments for Parkinson’s disease, motor neurone disease and other neurodegenerative diseases

- PMLiVE

NRG Therapeutics receives £2.68m Innovate UK Award

The funds will be used for research into new treatments for Parkinson’s and motor neurone disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links